We need an extra cup of stimulation this morning. We were so busy posting a gaggle of interesting items that we neglected to include our usual start-of-the-day greeting - it was queued up, but we never hit the send button. So sorry. Now, though, we believe we are on track, and we hope that you feel the same. To help you along, here are a few developments that caught our attention over the past few hours...
Memory Cuts Workforce By 20 Percent (Press Release)
AstraZeneca Faces August Trial For Seroquel Patent Dispute (Bloomberg News)
ImClone Offered $32M In Rebates (The Star-Ledger of New Jersey)
Daiichi-Sankyo Fails To Win FDA Approval For Anemia Med (Bloomberg News)